US3714191A - Dioxathiocin carboxylic acids, esters, salts and amides - Google Patents

Dioxathiocin carboxylic acids, esters, salts and amides Download PDF

Info

Publication number
US3714191A
US3714191A US00180117A US3714191DA US3714191A US 3714191 A US3714191 A US 3714191A US 00180117 A US00180117 A US 00180117A US 3714191D A US3714191D A US 3714191DA US 3714191 A US3714191 A US 3714191A
Authority
US
United States
Prior art keywords
dioxathiocin
compound
carbon atoms
carboxylic acid
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00180117A
Inventor
R Parker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Application granted granted Critical
Publication of US3714191A publication Critical patent/US3714191A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/10—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms two oxygen atoms and one sulfur atom, e.g. cyclic sulfates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Definitions

  • ABSTRACT Novel dioxathiocin carboxylic acids, esters, salts and amides which reduce blood lipids in warm blooded animals, are useful in the treatment of hyperlipidemic states and possess anti-infective properties, are represented by compounds of the following formula:
  • each Y, Y, Z and Z represent hydrogen, halogen such as chlorine, fluorine, bromine or iodine,
  • each set of Y and Y' or each set of Z and Z forms a napthalene ring which may be, unsubstituted or substituted with a substituent selected from a halogen atom such as chlorine, fluorine, bromine or iodine or lower alkyl of from one to four carbon atoms; W represents hydroxy, lower alkoxy of from one to four carbon atoms; or NRR R and R represent hydrogen or lower alkyl of from 1 to 4 carbon atoms and may be the same or different; or R and R taken together with the nitrogen atom to which each is attached form a saturated monocyclic heterocyclic group such as pyrrolidino, piperidino, morpholino, piperazino or N-(lower)-alkyl-piperazino.
  • a halogen atom such as chlorine, fluorine, bromine or iodine or lower alkyl of from one to four carbon atoms
  • W represents hydroxy, lower alkoxy of from one to four
  • This invention relates to novel dibenzo[d,g][ 1,3,61dioxathiocin, dinaphtho[2,l-d:l, 2-g][l,3,6]di oxathiocin, and dinaphtho[ l ,2-d:-2',1 -g][ I,3,6]dioxathiocin carboxylic acids, esters, salts, and amides which reduce blood lipids in warm blooded animals, are useful in the treatment of hyperlipidemic states and possess anti-infective properties.
  • novel compounds of this invention are l5 represented by the following formula,
  • each Y, Y, Z and Z represents hydrogen, halogen such as chlorine, fluorine, bromine or iodine, or lower alkyl of from one to four carbon atoms; or each set of Y and Y or each set of Z and 2' taken together with the aromatic ring to which each is attached forms a naphthalene ring which may be unsubstituted or substituted with a substituent selected from a halogen atom such as chlorine, fluorine, bromine or iodine or lower alkyl of from one to four carbon atoms; W represents hydroxy or lower alkoxy of from one to four carbon atoms or -NRR R and R represent hydrogen or lower alkyl of from one to four carbon atoms and may be the same or different; or R and R taken together with the nitrogen atom to which each is attached form a saturated monocyclic heterocyclic group such as 'pyrrolidino, pipe
  • Formula I compounds of this invention can be dibenzo[d,g][l,3,6]dioxathio cin derivatives as represented by the following Formula Formula II 12 11 Formula 111 I 168 8 H-(l-W 59 mi 14 v 12 R Formula IV
  • each of Z, Z, Y, Y and R represent hydrogen, halogen such as chlorine, fluorine, bromine or iodine, or lower alkyl of from one to four carbon atoms and W has the meaning defined hereinbefore.
  • novel compounds of this invention reduce blood lipids, particularly lipoproteins containing cholesterol and triglycerides in warm-blooded animals and are useful in thetreatment of hyperlipidemic states such as are encountered in patients with cardiovascular diseases, especially atherosclerotic diseases that can result in heart failure and stroke. Also, the compounds of this invention possess anti-infective properties.
  • the compounds of this invention can be used in th form'of pharmaceutical preparations which contain the novel compound suitable for oral or parenteral administration.
  • the quantity of compound in unit dosage form can vary a wide range to provide from about 0.5 mg/kg'to about 4 g/kg of body weight and preferably 1 mg/kg to 1 g/kg of body weight of the subject per day to achieve the desired effect.
  • compounds of this invention when administered subcutaneously havebeen found to be effective in mice against certain types of viruses,'for-example, encephalomyocarditis; bacteria, for example Staphylococcus aureus and Salmonella schottmuelleri; and fungi, for example, Candida albicans.
  • viruses for-example, encephalomyocarditis
  • bacteria for example Staphylococcus aureus and Salmonella schottmuelleri
  • fungi for example, Candida albicans.
  • the compounds of this invention are prepared be reacting one equivalent of a compound of the formula Formula VII or a salt thereof and at least two equivalents of dihaloacetate salt, for example, dichloroacetate salt, in a suitable solvent and in the presence of excess base to give dioxathiocin carboxylate salts of Formula VII];
  • the two or more equivalents of the dihaloacetate salt reactant can all be added at the start of the reaction, it is preferred that one equivalent of the dihaloacetate salt reactant is placed in the reaction mixture initially, and then at a period of from about to 48 hours from the start of the reaction one or more equivalents of the dihaloacetate salt is added to the reaction mixture.
  • the salts of the thio-bisphenol or thio-bis-naphthol reactant and dihaloacetic acid are prepared in situ by addition of base.
  • bases can be used such as, for example, potassium carbonate, sodium methoxide, potassium tert-butoxide, sodium hydroxide or potassium hydroxide.
  • the preferred base is potassium carbonate, however, when substituted thio-bisphenols which have weaker acid values are used, it may be necessary to use a stronger base such as sodium methoxide or potassium tert-butoxide.
  • solvents suitable for use in the reaction there may be mentioned, for example, ethanol, npropanol, isopropanol, n-butanol, tert-butanol, dimethylformamide, dimethylsulfoxide, water and the like.
  • the preferred solvents are n-propanol and isopropanol.
  • reaction mixture is heated to reflux with vigorous stirring for 10 to 120 hours, preferably 98 hours, after which the solvent is distilled off and replaced with water.
  • the mixture is cooled and the product, a compound of Formula VIII, is collected, which may be converted to the acid by suspending it in water and acidifying the mixture with, for example, hydrochloric acid.
  • the precipitate is collected and recrystallized from, for example, toluene or acetic acid to give the dibenzo [d,g][l,3,6]dioxathiocin-6-carboxylic acids, that is, compounds of Formula I] wherein W represents hydroxy, and the dinaphtho[2,l-d:l,2'-g] [1,3,61dioxathiocin-8-carboxylic acids, that is, compounds of Formulas 111 wherein W represents hydroxy, or dinaphtho[ 1 ,2-d:2',l '-g][ l ,3,6]dioxathiocin-8-carboxylic acids, that is, compounds of Formula 1V wherein W is hydroxy.
  • the corresponding lower alkyl esters may be prepared by esterification of the above mentioned acids with lower aliphatic alcohols by generally known esterification procedures.
  • the corresponding dioxathiocin carboxamides may be obtained by the action of ammonia, or an appropriate primary amine such as ethylamine or propylamine, or an appropriate secondary amine such as dimethylamine, diethylamine, piperidine, morpholine, N-methylpiperazine and the like, on the acid halide or the ester of the above mentioned dioxathiocin carboxylic acids.
  • the ester derivative may be obtained by the procedure described hereinbefore, and the acid halide may be obtained by reacting the dioxathiocin carboxylic acid with thionyl halide, for example, thionyl chloride by generally known procedures.
  • the reactant thiobisphenols and thiobisnaphthols that is, compounds of Formula VII are prepared by reacting, 2 moles of an appropriately substituted phenol or naphthol with 1 mole of sulfur dichloride in the presence of a Lewis acid and under conditions generally employed for a Friedel-Crafts reaction.
  • EXAMPLE 3 Dinaphtho[2,1-d:l ',2'-g] 1 ,3,6]dioxathiocin-8- carboxylic acid
  • each of Y,Y, Z, and Z is selected from the group consisting of hydrogen, halogen, or a lower alkyl radical of from one to four carbon atoms; or each set of Y and Y or each set of Z and Z taken together with the aromatic ring to which each set is attached forms a naphthalene ring which may be unsubstituted or substituted with a substituent selected from a halogen atom, or a lower alkyl radical of from one to four carbon atoms; W is selected from the group consisting of hydroxy, a lower alkoxy radical of from one to four carbon atoms or NR'R wherein each of R and R is selected from the group consisting of hydrogen or a lower alkyl radical of from one to four carbon atoms, or R and R taken together with the nitrogen atom to which each is attached form a saturated monocyclic heterocyclic group selected from pyrrolidino, piperidino, morpholino, piperazino, or
  • W is selected from hydroxy or a lower alkoxy radical of from one to four carbon atoms.
  • each of Y, Y, Z, and Z is selected from hydrogen, halogen or a lower alkyl radical of from one to four carbon atoms.
  • a compound of claim 3 which is 2,10-dimethyldibenzo[d,g][ l ,3,6]dioxathiocin-o-carboxylic acid.
  • a compound of claim 3 which is methyl 2, l 0dimethyldibenzo-[d,g][ l ,3,6]dioxathiocin-6-carboxylate.
  • each of Y, Y, Z, and Z is selected from hydrogen or chlorine.
  • a compound of claim 6 which is methyl 2,4,8,l0- tetrachlorodibenzo[d,g][ l,3,6]dioxathiocin-6-carboxylate.
  • a compound of claim 6 which is methyl 2,10- dichlorodibenzo[d,g]ey[ l,3,6]dioxathiocin-6-carboxylate.
  • each set of Z and Z taken together with the aromatic ring to which each set is attached form a naphthalene ring which may be unsubstituted or substituted with a halogen atom, or a lower alkyl radical of from one to four carbon atoms.
  • a compound of claim 12 which is dinaphtho[2,ld: l ',2-g][ l ,3,61dioxathiocin-8-carboxylic acid.
  • each set of Y and Y taken together with the aromatic ring to which each set is attached forms a naphthalene ring which may be unsubstituted or substituted with a halogen atom, or a lower alkyl radical of from one to four carbon atoms.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Novel dioxathiocin carboxylic acids, esters, salts and amides, which reduce blood lipids in warm blooded animals, are useful in the treatment of hyperlipidemic states and possess anti-infective properties, are represented by compounds of the following formula:
WHEREIN EACH Y, Y'', Z and Z'' represent hydrogen, halogen such as chlorine, fluorine, bromine or iodine, or lower alkyl or from one to four carbon atoms; or each set of Y and Y'' or each set of Z and Z'' forms a napthalene ring which may be unsubstituted or substituted with a substituent selected from a halogen atom such as chlorine, fluorine, bromine or iodine or lower alkyl of from one to four carbon atoms; W represents hydroxy, lower alkoxy of from one to four carbon atoms; or -NR1R2; R1 and R2 represent hydrogen or lower alkyl of from 1 to 4 carbon atoms and may be the same or different; or R1 and R2 taken together with the nitrogen atom to which each is attached form a saturated monocyclic heterocyclic group such as pyrrolidino, piperidino, morpholino, piperazino or N-(lower)-alkyl-piperazino.

Description

United States Patent 1 i Parker 1 1 Jan.30, 1973 [541 DIOXATHIOCIN CARBOXYLIC ACIDS,
ESTERS, SALTS AND AMIDES [75] Inventor: Roger Alan Parker, Cincinnati,
Ohio
[73] Assignee: Richardson Merre1lInc.,New York,
[22] Filed: Sept. 13, 1971 21 Appl. No.: 180,117
[5 6] References Cited OTHER PUBLICATIONS Adams, Chemical Abstracts, 5321213 (1-1959) Primary Examiner-Henry R. .liles Assistant ExaminerCecilia M. S. Jaisle Attorney-Eugene O. Retter et al.
[57] ABSTRACT Novel dioxathiocin carboxylic acids, esters, salts and amides, which reduce blood lipids in warm blooded animals, are useful in the treatment of hyperlipidemic states and possess anti-infective properties, are represented by compounds of the following formula:
Formula I wherein each Y, Y, Z and Z represent hydrogen, halogen such as chlorine, fluorine, bromine or iodine,
, or lower alkyl or from one to four carbon atomsgor each set of Y and Y' or each set of Z and Z forms a napthalene ring which may be, unsubstituted or substituted with a substituent selected from a halogen atom such as chlorine, fluorine, bromine or iodine or lower alkyl of from one to four carbon atoms; W represents hydroxy, lower alkoxy of from one to four carbon atoms; or NRR R and R represent hydrogen or lower alkyl of from 1 to 4 carbon atoms and may be the same or different; or R and R taken together with the nitrogen atom to which each is attached form a saturated monocyclic heterocyclic group such as pyrrolidino, piperidino, morpholino, piperazino or N-(lower)-alkyl-piperazino.
14 Claims, N0 Drawings DIOXATI-IIOCIN CARBOXYLIC ACIDS, ESTERS; SALTS AND AMIDES FIELD OF INVENTION 7 This invention relates to novel dibenzo[d,g][ 1,3,61dioxathiocin, dinaphtho[2,l-d:l, 2-g][l,3,6]di oxathiocin, and dinaphtho[ l ,2-d:-2',1 -g][ I,3,6]dioxathiocin carboxylic acids, esters, salts, and amides which reduce blood lipids in warm blooded animals, are useful in the treatment of hyperlipidemic states and possess anti-infective properties.
SUMMARY OF THE INVENTION The novel compounds of this invention are l5 represented by the following formula,
i l cH-b-W ,z' -0 Formula I wherein each Y, Y, Z and Z represents hydrogen, halogen such as chlorine, fluorine, bromine or iodine, or lower alkyl of from one to four carbon atoms; or each set of Y and Y or each set of Z and 2' taken together with the aromatic ring to which each is attached forms a naphthalene ring which may be unsubstituted or substituted with a substituent selected from a halogen atom such as chlorine, fluorine, bromine or iodine or lower alkyl of from one to four carbon atoms; W represents hydroxy or lower alkoxy of from one to four carbon atoms or -NRR R and R represent hydrogen or lower alkyl of from one to four carbon atoms and may be the same or different; or R and R taken together with the nitrogen atom to which each is attached form a saturated monocyclic heterocyclic group such as 'pyrrolidino, piperidino, morpholino, piperazino or N-(lower)-alkyl-piperazino.
As can be seen from the above Formula I compounds of this invention can be dibenzo[d,g][l,3,6]dioxathio cin derivatives as represented by the following Formula Formula II 12 11 Formula 111 I 168 8 H-(l-W 59 mi 14 v 12 R Formula IV In the above Formulas II, III, and IV each of Z, Z, Y, Y and R represent hydrogen, halogen such as chlorine, fluorine, bromine or iodine, or lower alkyl of from one to four carbon atoms and W has the meaning defined hereinbefore.
DETAILED DESCRIPTION OF INVENTION The most preferred compounds of this invention are represented by the following Formulas V and VI:
Formula V Formula VI As examples of compounds of this invention there may be mentioned, for example,
2,l-dichlorodibenzo[d,g][1,3,6]dioxathiocin-6- carboxylic acid, dinaphtho[2,l-d:l,2-g][1,3,6]dioxathiocin-8-carboxylic acid, 2,4,8,]O-tetrachlorodibenzo[d,g,][1,3 ,6]dioxathiocin-6--carboxylic acid, methyl dioxathiocin-6carboxylate, 2,4,8,10-tetrachloroclibenzo[d,g,][ 1,3,61dioxathiocin carboxamide, ethyl 2,14-dimethyldinaphtho[2,l-d:1,2'-g]dioxathiocin-8-carboxylate, 4,12-dibromodinaphtho[2,l-d:l ',2'-g]dioxathiocin- 8-carboxamide,
3,13-diethyldinaphtho[2,l-dzl ,2'-g]dioxathiocin-8- carboxylic acid, 2,10-dichlorodinaphtho[1,2-d:2,l'-g]dioxathiocin- 8-carboxylic acid,
N,N-diethyl-5,l l-dipropyldinaphtho[2, l -d:l ',2'-
g]dioxathiocin-8-carboxamidc, 2,l-4-difluoro-N,N-dipropyldibenzo[d,g][1,3,61dioxathiocin-tS-carboxamide,
3,9-diethyldibenzo[d,g][ l ,3,6]dioxathiocin-6-carboxylic acid,
ethyl 2,4,8,l0-tetrapropyldibenzo[d,g,][ l,3,6]dioxathiocin-6-carboxylate, l,l1N,N-tetramethyldibenzo[d,g][l,3,6]dioxathiocin-6-carboxamide, 1-(dibenzo[d,g,][1,3,6]dioxathiocin-6-carbonyl)piperidine,
l-(2,10-dimethyldibenzo[d,g][ l ,3,6]dioxathiocin-6- carbonyl)pyrrolidine,
l-(2, l O-dichlorodibenzo[d,g,][ l ,3,6]dioxathiocin-6- carbonyl)piperazine, l-(2,10-dichlorodibenzo[d,g][ l ,3,6]dioxathiocin-6- carbonyl)-4propylpiperazine, 1-(2,lO-dipropylidibenzo[d,g][1,3 ,6 ]dioxathiocin-6- carbonyl)morpho1ine, and the like.
The novel compounds of this invention reduce blood lipids, particularly lipoproteins containing cholesterol and triglycerides in warm-blooded animals and are useful in thetreatment of hyperlipidemic states such as are encountered in patients with cardiovascular diseases, especially atherosclerotic diseases that can result in heart failure and stroke. Also, the compounds of this invention possess anti-infective properties.
The compounds of this invention can be used in th form'of pharmaceutical preparations which contain the novel compound suitable for oral or parenteral administration. The quantity of compound in unit dosage form can vary a wide range to provide from about 0.5 mg/kg'to about 4 g/kg of body weight and preferably 1 mg/kg to 1 g/kg of body weight of the subject per day to achieve the desired effect.
To illustrate the utility of the compounds of this invention young male rats of the Wistar strain weighing initially about 170 grams were given free access to a diet to which the indicated amount of test compound was added. This diet was prepared by thoroughly mixing the compound with commercial PURlNA CHOW (Trademark of Ralston Purina Company, St. Louis, Miss.). .Groups of animals were given these diets for a period of 10 days. Control groups were given the same diet with no added drug. At the end of the treatment 2,4,8,l0-tetrachlorodibenzo[d,g,][1,3,6]
period, all rats were bled by cardiac puncture and the plasma was analyzed for cholesterol and triglyceride content on a Technicon AUTOANALYZER (*Trademark of Technicon Corporation, Tarrytown, N.Y. 10591.). The results are given in the following Table 1.
(a) Determined by measuring food consumption. b) Compared to untreated control rats in the same experiment.
Other compounds of this invention show comparable results when administered under similar conditions.
As antiinfectives, compounds of this invention when administered subcutaneously havebeen found to be effective in mice against certain types of viruses,'for-example, encephalomyocarditis; bacteria, for example Staphylococcus aureus and Salmonella schottmuelleri; and fungi, for example, Candida albicans.
The compounds of this invention are prepared be reacting one equivalent of a compound of the formula Formula VII or a salt thereof and at least two equivalents of dihaloacetate salt, for example, dichloroacetate salt, in a suitable solvent and in the presence of excess base to give dioxathiocin carboxylate salts of Formula VII];
I g I (Bu-(mo ma Formula VIII The various symbols, Y, Y, Z and Z in the above Formulas VII and VIII have the meaning defined as in Formula l, and M represents an inorganic salt forming radical.
Although the two or more equivalents of the dihaloacetate salt reactant can all be added at the start of the reaction, it is preferred that one equivalent of the dihaloacetate salt reactant is placed in the reaction mixture initially, and then at a period of from about to 48 hours from the start of the reaction one or more equivalents of the dihaloacetate salt is added to the reaction mixture.
The salts of the thio-bisphenol or thio-bis-naphthol reactant and dihaloacetic acid are prepared in situ by addition of base. A variety of bases can be used such as, for example, potassium carbonate, sodium methoxide, potassium tert-butoxide, sodium hydroxide or potassium hydroxide. The preferred base is potassium carbonate, however, when substituted thio-bisphenols which have weaker acid values are used, it may be necessary to use a stronger base such as sodium methoxide or potassium tert-butoxide.
As examples of solvents suitable for use in the reaction there may be mentioned, for example, ethanol, npropanol, isopropanol, n-butanol, tert-butanol, dimethylformamide, dimethylsulfoxide, water and the like. The preferred solvents are n-propanol and isopropanol.
The reaction mixture is heated to reflux with vigorous stirring for 10 to 120 hours, preferably 98 hours, after which the solvent is distilled off and replaced with water. The mixture is cooled and the product, a compound of Formula VIII, is collected, which may be converted to the acid by suspending it in water and acidifying the mixture with, for example, hydrochloric acid. The precipitate is collected and recrystallized from, for example, toluene or acetic acid to give the dibenzo [d,g][l,3,6]dioxathiocin-6-carboxylic acids, that is, compounds of Formula I] wherein W represents hydroxy, and the dinaphtho[2,l-d:l,2'-g] [1,3,61dioxathiocin-8-carboxylic acids, that is, compounds of Formulas 111 wherein W represents hydroxy, or dinaphtho[ 1 ,2-d:2',l '-g][ l ,3,6]dioxathiocin-8-carboxylic acids, that is, compounds of Formula 1V wherein W is hydroxy.
The corresponding lower alkyl esters may be prepared by esterification of the above mentioned acids with lower aliphatic alcohols by generally known esterification procedures.
The corresponding dioxathiocin carboxamides may be obtained by the action of ammonia, or an appropriate primary amine such as ethylamine or propylamine, or an appropriate secondary amine such as dimethylamine, diethylamine, piperidine, morpholine, N-methylpiperazine and the like, on the acid halide or the ester of the above mentioned dioxathiocin carboxylic acids. The ester derivative may be obtained by the procedure described hereinbefore, and the acid halide may be obtained by reacting the dioxathiocin carboxylic acid with thionyl halide, for example, thionyl chloride by generally known procedures.
The reactant thiobisphenols and thiobisnaphthols, that is, compounds of Formula VII are prepared by reacting, 2 moles of an appropriately substituted phenol or naphthol with 1 mole of sulfur dichloride in the presence of a Lewis acid and under conditions generally employed for a Friedel-Crafts reaction.
EXAMPLES Representative compounds of the invention and their preparation are illustrated in the following specific examples.
EXAMPLE 1 2,4,8,10-Tetrachlorodibenzo[d,g][ l ,3,6]dioxathiocin- 6-carboxylic acid 50 g (0.141 mole) of 2,2-thiobis(4,6- dichlorophenol), 36.2 g (0.282 mole) ofpotassium carbonate, 5.0 g (0.03 mole) of potassium iodide, 18.2 g (0.141 mole) of dichloroacetic acid and 500 ml of npropanol were combined and refluxed with vigorous stirring for 48 hours after which 36.2 g (0.282 mole) of potassium carbonate and 18.2 g (0.141 mole) of dichloroacetic acid were added. The mixture was refluxed with stirring an additional 24 hours, then the solvent was removed by distillation being gradually replaced with water. The mixture was allowed to cool, and the precipitate was collected and washed with 500 ml of 2 percent aqueous potassium hydroxide. The solid was suspended in 1 liter of water to which was added hydrochloric acid until the mixture was acidic to litmus paper. The resulting solid was washed washed with water, dried and recrystallized twice from toluene to give 24 g of the desired product, M.P. 231-233C (dec.).
EXAMPLE 2 Methyl 2,4,8,10-tetrachlorodibenzo[d,g][1 ,3,6] dioxathiocin-6-carboxylate To 500 ml of methanol containing 5 ml of concentrated sulfuric acid was added 20.0 g (0.05 mole) of 2,4,8, 1 0-tetrachlorodibenzo[d,g][ l ,3 ,6]dio'xathiocin- 6-carboxylic acid, and the mixture was refluxed for 3 hours. Upon cooling the resulting crystalline product was recrystallized from acetone-methanol to give 16.8 g of the desired product, M.P. l54-l 56C.
EXAMPLE 3 Dinaphtho[2,1-d:l ',2'-g] 1 ,3,6]dioxathiocin-8- carboxylic acid A mixture of 50.0 g (0.157 mole) of 1,l-thiodi-B- naphthol, 87.0 g (0.628 mole) of potassium carbonate, 5.0 g (0.03 mole) of potassium iodide, 20.3 g (0.157 mole) of dichloroacetic acid and 600 ml of n-propanol was refluxed with vigorous stirring for 24 hours after which an additional 20.3 g (0.157 mole) of dichloroacetic acid was added. The mixture was refluxed with stirring an additional 64 hours, then the solvent was distilled off being gradually replaced with water. The mixture was colled and the resulting precipitate was dried and recrystallized twice from toluene to give the desired product, M.P. 233238C (dec.).
EXAMPLE 4 2,10-Dichlorodibenzo[d,g][ 1,3 ,6]dioxathiocin-6- carboxylic acid Substituting an appropriate amount of 2,2'-thiobis(4 5 1| -chlorophenol) for 2,2-thiobis(4,6-dichlorophenol) in the procedure of Example 1, the desired product was obtained, M.P. 224-227C.
EXAMPLE 5 Methyl 2,10-dichlorodibenzo[d,g][ l ,3,6]dioxathiocin- 6-carboxylate Substituting 2,10-dichlorodibenzo[d,g][ l ,3,6]dioxathiocin-6-carboxylic acid for 2,4,8, 1 O- tetrachlorodibenzo[d,g,[ l,3,6ldioxathiocin--carboxylic acid in the procedure of Example 2, the desired product was obtained, M.P. l96l98C.
EXAMPLE 6 n-Propyl2,4,8,lO-tetrachlorodibenzo[d,g,][1,3,6] dioxathiocin-o-carboxylate By the procedure of Example 2 only substituting npropanol for methanol the desired product is obtained.
EXAMPLE 7 2,4,8,lO-Tetrachlorodibenzo[d,g][ l ,3,6]dioxathiocin- -carboxamide A mixture of 2,4,8,lO-tetrachlorodibenzo[d,g,] [l,3,6]dioxathiocin-6-carboxylic acid and excess thionyl chloride is refluxed for 2 hours'after which the thionyl chloride is removed by distillation under reduced pressure affording the acid chloride. This acid chloride is slowly added to an excessof cold strong ammonia with stirring. The temperature of the reaction is kept below C with an ice bath. The reaction mixture is diluted with water and the resulting precipitate collected to give the desired product.
EXAMPLE 8 By the procedure of Example 7, only substituting for ammonia, approximately a l0 fold excess of diethylamine, piperidine, morpholine, or N-methylpiperazine dissolved in approximately a two fold volume of water the following compounds are obtained:
N,N-diethyl-2,4,8,lO-tetrachlorodibenzo[d,g,
l ,3,6]dioxathiocin-6-carboxamide, l-(2,4,8,l O-tetrachlorodibenzo[d,g,][ l ,3,6]dioxathiocin-fi-carbonyl)-piperidine, l-(2,4,8,lO-tetrachlorodibenzo[d,g,][1,3,6]dioxathiocin-o-carbonyl)-morpholine,
l-(2,4 ,8, l O-tetrachlorodibenzo[d,g,][ l ,3,6]dioxathiocin--carbonyl)-4-methylpiperazine By the procedureof Example I only substituting for 2,2-thiobis-(4,6dichlorophenol) an appropriate amount of the phenolslisted in Table 2 the respective products listed in Table 2 are obtained.
TABLE 2 Example No. Phenol Product 9 2,2'-thiodiphenol dibenzo[d,g,][ l,3,6]di
oxathiocin-6- carboxylic acid 2,10-difluorodibenzo 8,l-[ l l oxathiocin-ocarboxylic acid dibromodibenzo[d,g,d l-[ ldioxathiocin-t'acarboxylic acid l ,2,4,8,l0,l l-hex amethyldibenzo[d,g,][ l ,3,6] dioxathiocin-6- carboxylic acid l,2,3,4,8,9,l0,l loctachlorodibenzo[d ,gJl i l oxathiocin-6- carboxylic acid l,2,4,8,l0,l l-hexachlor0dibenzo[d,g,]
[1,3,6]di oxathiocin-6 carboxylic acid.
2,2'-thiobis(4-fluorophenol) 2,2'-thiobis(4-bromophenol) 6,6'-thiodipseudocumenol l3 2,2'-thiobis(tetrachlorophenol) 2,2'-thiobis(3,4,6-trichlorophenol) By the procedure of Example 3 only substituting for l,l-thiodi-B-naphthol an appropriate amount of the naphthols listed in Table 3 the respective products listed in Table 3 are obtained.
2,10-Dimethyldibenzo[d,g][ l ,3 ,6]dioxathiocin-6- carboxylic acid By the procedure of Example I only substituting for 2,2-thiobis(4,6-dichlorophenol) an appropriate amount of 2,2'-thiodi-p-cresol, the desired product was obtained, M.P. l9820l (dec.).
EXAMPLE 20 Methyl 2, l 0-dimethyldibenzo[d,g][ l ,3,6]dioxathiocin- 6-carboxylate By the procedure of Example 2, only substituting for 2,4,8, 1 O-tetrachlorodibenzo[d,g][ l ,3,6]dioxathiocin- 6-carboxylic acid, an appropriate amount of 2,10-
dimethyldibenzo[d,g]fc[ l ,3,6]dioxathiocin--carboxylic acid the desired compound was obtained, M.P. 104-106C.
EXAMPLEZI By the procedure of Example 7 only substituting for 2,4,8 ,10-tetrachlorodibenzo[d,g]l l ,3,6]dioxathiocin- -carboxylic acid appropriate amounts of l,2,4,8,l0,l 1-hexamethyldibenzo[d,g][1,3,61dioxathiocin-6-carboxylic acid, dibenzo[d,g][l,3,6]dioxathiocin-6-carboxylic acid and dinaphtho[2,l-d:l',2'- g][l,3,6]dioxathiocin-8-carboxylic acid and substituting excess dipropylamine, dissolved in a two fold volume of water, for ammonia the following compounds are obtained:
N,N-dipropyl-l ,2,4,8,l0,1 l-hexamethyldibenzo[d,g
][l,3,6]dioxathiocin-6-carboxylic acid N,N-dipropyldibenzo[d,g]1,3 ,6ldioxathiocin-6-carboxamide,
N,N-dipropyldinaphtho[2, l -d:l ',2'-g]ll,3,6]dioxathiocin-8-carboxamide.
I claim:
1. A compound of the formula wherein each of Y,Y, Z, and Z is selected from the group consisting of hydrogen, halogen, or a lower alkyl radical of from one to four carbon atoms; or each set of Y and Y or each set of Z and Z taken together with the aromatic ring to which each set is attached forms a naphthalene ring which may be unsubstituted or substituted with a substituent selected from a halogen atom, or a lower alkyl radical of from one to four carbon atoms; W is selected from the group consisting of hydroxy, a lower alkoxy radical of from one to four carbon atoms or NR'R wherein each of R and R is selected from the group consisting of hydrogen or a lower alkyl radical of from one to four carbon atoms, or R and R taken together with the nitrogen atom to which each is attached form a saturated monocyclic heterocyclic group selected from pyrrolidino, piperidino, morpholino, piperazino, or N-(lower)-alkylpiperazino.
2. A compound of claim 1 wherein W is selected from hydroxy or a lower alkoxy radical of from one to four carbon atoms.
3. A compound of claim 2 wherein each of Y, Y, Z, and Z is selected from hydrogen, halogen or a lower alkyl radical of from one to four carbon atoms.
4. A compound of claim 3 which is 2,10-dimethyldibenzo[d,g][ l ,3,6]dioxathiocin-o-carboxylic acid.
5. A compound of claim 3 which is methyl 2, l 0dimethyldibenzo-[d,g][ l ,3,6]dioxathiocin-6-carboxylate.
6. A compound of claim 3 wherein each of Y, Y, Z, and Z is selected from hydrogen or chlorine.
7 A compound of claim 6 which is carboxylic acid.
8. A compound of claim 6 which is methyl 2,4,8,l0- tetrachlorodibenzo[d,g][ l,3,6]dioxathiocin-6-carboxylate.
9. A compound of claim 6 which is 2,10-
diclorodibenzo[d,g]e[ 1,3,6 ]dioxathiocin--carboxylic acid.-
10. A compound of claim 6 which is methyl 2,10- dichlorodibenzo[d,g]ey[ l,3,6]dioxathiocin-6-carboxylate.
11. A compound of claim 1 wherein each set of Z and Z taken together with the aromatic ring to which each set is attached form a naphthalene ring which may be unsubstituted or substituted with a halogen atom, or a lower alkyl radical of from one to four carbon atoms.
12. A compound of claim 11 wherein W is selected from hydroxy or a lower alkoxy of from one to four carbon atoms.
13. A compound of claim 12 which is dinaphtho[2,ld: l ',2-g][ l ,3,61dioxathiocin-8-carboxylic acid.
14. A compound of claim 1 wherein each set of Y and Y taken together with the aromatic ring to which each set is attached forms a naphthalene ring which may be unsubstituted or substituted with a halogen atom, or a lower alkyl radical of from one to four carbon atoms.
UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 3 '71 L 1 Q'l Dated January 30 I Q7? Inven Rngnrma Parker It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
In the Abstract of line 5,- after formula 1, the second occurence of "or" should read -of-.
Signed and Sealed this thirt Day of January 1976 [SEAL] A ttes t."
RUTH C. MASON C. MARSHALL DANN Arresting Officer Commissioner ofPaIenls and Trademarks UNITED STATES PATENT AND TRADEMARK OFFICE CERTIFICATE OF CORRECTION PATENT NO. 1 3 714 1 1 DATED 1 January 50, 1973 INVENTOR(S) Roger Alan Parker It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below: I n the Abstract at Line 3 after Formula second occurence of "or" should read "of" Li ne l after Formula I through I ine 5 "each set of or sub-" should read "each set of Z and 2' taken together wi th the aromatic ring to which each is attached Forms a naphthalene ring which may be unsubstituted or substituted" Column 1,
Y' Yr 3 s Formula II should read @z- Column 5, l ine 54 Form can vary a wide range" should read "Form can var over a wide range".
Column "I, Table I at l ine 7 add 'Dai ly Dose" above columns 2 and 5; line 36 "be" should read "by"; Formula VIII CH-COO-M should read cH-coo'M. Column 6, line 31 -O/ "col led" should read "cooled". Column 8, l ine 6 "[d,g,d" should read [d,g]"; l ine 66 [d,g]fc" should read [d, g] Q Column 10, l ine 27 [d,g]e' should read [d,g]" l ine 5O [d,g]ey" should read "[d,g]".
Signed and Scaled this 0 second Day of December 1975 [SEAL] Arrest:
Q RUTH C. MASON C. MARSHALL DANN Arresting Offirer Commissioner oflarenls and Trademarks

Claims (13)

1. A compound of the formula
2. A compound of claim 1 wherein W is selected from hydroxy or a lower alkoxy radical of from one to four carbon atoms.
3. A compound of claim 2 wherein each of Y, Y'', Z, and Z'' is selected from hydrogen, halogen or a lower alkyl radical of from one to four carbon atoms.
4. A compound of claim 3 which is 2,10-dimethyldibenzo(d,g) (1, 3,6)dioxathiocin-6-carboxylic acid.
5. A compound of claim 3 which is methyl 2,10dimethyldibenzo-(d, g) (1,3,6)dioxathiocin-6-carboxylate.
6. A compound of claim 3 wherein each of Y, Y'', Z, and Z'' is selected from hydrogen or chlorine.
7. A compound of claim 6 which is 2,4,8,10tetrachlorodibenzo(d, g) (1,3,6)dioxathiocin-6-carboxylic acid.
8. A compound of claim 6 which is methyl 2,4,8,10-tetrachlorodibenzo(d,g) (1,3,6)dioxathiocin-6-carboxylate.
9. A compound of claim 6 which is 2,10-diclorodibenzo(d,g) (1,3, 6)dioxathiocin-6-carboxylic acid.
10. A compound of claim 6 which is methyl 2,10-dichlorodibenzo(d,g) (1,3,6)dioxathiocin-6-carboxylate.
11. A compound of claim 1 wherein each set of Z and Z'' taken together with the aromatic ring to which each set is attached form a naphthalene ring which may be unsubstituted or substituted with a halogen atom, or a lower alkyl radical of from one to four carbon atoms.
12. A compound of claim 11 wherein W is selected from hydroxy or a lower alkoxy of from one to four carbon atoms.
13. A compound of claim 12 which is dinaphtho(2,1-d:1'',2''-g) (1, 3,6)dioxathiocin-8-carboxylic acid.
US00180117A 1971-09-13 1971-09-13 Dioxathiocin carboxylic acids, esters, salts and amides Expired - Lifetime US3714191A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18011771A 1971-09-13 1971-09-13

Publications (1)

Publication Number Publication Date
US3714191A true US3714191A (en) 1973-01-30

Family

ID=22659258

Family Applications (1)

Application Number Title Priority Date Filing Date
US00180117A Expired - Lifetime US3714191A (en) 1971-09-13 1971-09-13 Dioxathiocin carboxylic acids, esters, salts and amides

Country Status (11)

Country Link
US (1) US3714191A (en)
JP (1) JPS5543473B2 (en)
AU (1) AU458572B2 (en)
BE (1) BE788770A (en)
CA (1) CA1016182A (en)
CH (1) CH569728A5 (en)
DE (1) DE2242841A1 (en)
FR (1) FR2154491B1 (en)
GB (1) GB1374370A (en)
NL (1) NL7212396A (en)
ZA (1) ZA725744B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553234A (en) * 1969-06-18 1971-01-05 Richardson Merrell Inc Dibenzo(d,g)(1,3)dioxocin-6-carboxylic acids, esters and salts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Adams, Chemical Abstracts, 53:1213 (1 1959) *

Also Published As

Publication number Publication date
AU4592472A (en) 1974-02-28
FR2154491B1 (en) 1975-08-08
NL7212396A (en) 1973-03-15
GB1374370A (en) 1974-11-20
CH569728A5 (en) 1975-11-28
JPS4836184A (en) 1973-05-28
AU458572B2 (en) 1975-02-27
JPS5543473B2 (en) 1980-11-06
FR2154491A1 (en) 1973-05-11
CA1016182A (en) 1977-08-23
BE788770A (en) 1973-01-02
ZA725744B (en) 1973-05-30
DE2242841A1 (en) 1973-03-22

Similar Documents

Publication Publication Date Title
US4058552A (en) Esters of p-carbonylphenoxy-isobutyric acids
SU698530A3 (en) Method of preparing aminoalkylheterocyclic compounds or their salts
US3784697A (en) Pharmaceutical composition containing phenoxyalkane-carboxylic acids,salts and esters thereof
JPS6260381B2 (en)
US3772275A (en) Antidepressive morpholino compounds and methods of producing the same
US3454643A (en) 5 - (tertiaryaminoalkylene)-5 hydroxy- and 5-(tertiary aminoalkylidene) - dibenzocycloheptatrienes,and salts thereof
US2489950A (en) Basic-alkyl esters and their salts
US3534085A (en) 5,8-dihydronaphthloxy-aminopropanols and related compounds
US3714191A (en) Dioxathiocin carboxylic acids, esters, salts and amides
US4390537A (en) 1-(Substituted-aminoalkoxyphenyl)-2-methylene-1-alkanones, compositions and use
US3324121A (en) Alpha-(secondary aminomethyl)acylphenoxy (and phenylmercapto) monocarboxylic acids
US4719310A (en) Ester and amide substituted (2,3-dihydro-4-(3-oxo-1-cyclohexen-1-yl)phenoxy)alkanoic acids and their salts
US4233298A (en) Esters of p-carbonylphenoxy-isobutyric acids
US3532742A (en) Octalone carboxylic acids and their derivatives
US3255242A (en) (alpha-alkylideneacyl)naphthyloxy monocarboxylic acids
US3077472A (en) 3-[4-(aminoalkoxy)-phenyl]-4-(4-oxyphenyl)-alkanes and alkenes
US3931173A (en) Dioxocin carboxamide derivatives
US2538794A (en) Alkamine esters of delta-cyclohexenylalkylacetic acids
US4440787A (en) Compounds with antiinflammatory and analgesic activity, process for the preparation thereof and pharmaceutical compositions therefrom
US3455918A (en) Alpha,alpha,alpha - trihalogeno - beta,beta - bis(para - tertiary-aminoalkoxy-phenyl)-ethanes
US3163649A (en) Substituteb phenyl-piperazine
US3190893A (en) Method of producing 9, 10-dihydroanthracenes
US3449419A (en) (4-phenoxy-3,5-dihalophenyl)alkanoamides
US3389170A (en) 3-acylamino-2, 4, 6-triiodo-benzoic acids
US3668206A (en) Heterocyclic amine derivatives of 5,8-dihydronaphthyloxy propanols